Microdosing Trials, Human

Download in:

Switch to

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
umls-concept:C1720829	rdf:type	umls-semnetwork:T062	lld:umls
umls-concept:C1720829	rdf:type	skos:Concept	lld:umls
umls-concept:C1720829	calbc:hasCorrelation	calbc-group:PROC	lld:calbc
umls-concept:C1720829	skos:definition	MSH: Use of doses at only 1% of the pharmacological dose in humans in order to evaluate the pharmacokinetics. Such trials are sometimes referred to as phase zero trials.	lld:umls
umls-concept:C1720829	skos:inScheme	lld:umls	lld:umls
umls-concept:C1720829	skos-xl:prefLabel	umls-label:A10908684	lld:umls
umls-concept:C1720829	skos-xl:altLabel	umls-label:A10907119	lld:umls
umls-concept:C1720829	skos-xl:altLabel	umls-label:A10908683	lld:umls
umls-concept:C1720829	skos-xl:altLabel	umls-label:A10911533	lld:umls
umls-concept:C1720829	skos-xl:altLabel	umls-label:A10907118	lld:umls
umls-concept:C1720829	skos-xl:altLabel	umls-label:A10911534	lld:umls
umls-concept:C0920321	skos:narrower	umls-concept:C1720829	lld:umls
http://linkedlifedata.com/r...	umls:relatedConcept	umls-concept:C1720829	lld:umls